Emily McGinnis

Emily McGinnis

Company: Taysha Gene Therapies

Job title: Chief Patient Officer & Head


Emily had strategic oversight of patient advocacy and government affairs for the preparation and successful launch AveXis’ gene therapy for Spinal Muscular Atrophy (SMA) for the last 3 1/2 years.  Emily  focused her efforts on ensuring the patient voice is at the center of the organization from clinical trial planning, understanding unmet needs to inform educational efforts and co-creating materials to support commercialization.  In addition, Emily has collaborated with advocacy partners drive earlier diagnosis for SMA and newborn screening efforts for SMA.  Emily has worked in many roles in the biotechnology industry over 17 years, including specialty sales, product launches in rare diseases, leading medical affairs efforts, and patient advocacy.  Emily holds a master’s degree in Public Health from University of Illinois at Chicago.


Best Practices for Defining & Enrolling Clinical Trials with Patients & Families at Core 5:00 pm

Gaining feedback from advocacy groups, patients and families on clinical trial design Collaborating with advocacy partners to enhance patient recruitment Collaborating with advocacy, patients and families to co-create educational materials for recruitmentRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.